--Appoints Experienced Technology Executives to lead Product and Marketing 

Suvoda LLC, an innovator in clinical trial software, today announced the 
expansion of its leadership team with the appointments of E.K. Koh to the 
position of Chief Product Officer and Elena Filimonova to the position of Chief 
Marketing Officer. Filimonova and Koh come to Suvoda with extensive backgrounds 
in B2B technology and years of experience building and scaling customer-centric 
organizations.

Logo - https://mma.prnewswire.com/media/1039295/Suvoda_Logo.jpg

For the past eight years, fast market adoption has driven Suvoda's rapid growth 
and established the company as a leader in the clinical trial technology space. 
Fueled by the recent investment from LLR Partners, Suvoda is scaling its 
organization to support the growth while remaining laser-focused on expanding 
its product functionality and upholding the superior level of customer support 
for which the company is known. 

As the industry shifts towards patient-centricity and trial virtualization, and 
as trials themselves become more complex, Koh and his team will focus on 
creating scalable solutions that provide greater efficiency in patient and 
supply chain management to help clinical trial sponsors get new therapies to 
patients faster.

Koh is an experienced product executive with a track record of scaling product 
organizations, as well as defining and executing disruptive solutions with 
strong product-market fit. He has an extensive background in product management 
and development with companies like Experian, LiveRamp and Optymyze, among 
others. 

"I am personally motivated by Suvoda's mission to improve the lives of 
patients," said Koh. "Clinical trials are ripe for product disruption, and I'm 
excited to contribute to a company that combines transformative innovation with 
an unparalleled focus on improving study execution."

As Chief Marketing Officer, Filimonova will drive worldwide brand and 
go-to-market strategy with targeted marketing initiatives to support Suvoda's 
business and growth goals.

"Suvoda is an exceptional company centered around a great team, innovative 
products, and an outstanding level of customer service. I am honored to be part 
of it. I am committed to further growing Suvoda's presence and elevating the 
company's voice as an innovator in the clinical trial space by highlighting its 
unique capabilities and expertise."

Filimonova has spent most of her career in B2B technology marketing. Her 
experience and strategic focus have helped both start-ups and established 
companies gain market recognition, drive growth, and bring new products to 
market. Prior to joining Suvoda, Filimonova held marketing leadership positions 
at Radianz, a Reuters-owned company, Knovel, Elsevier, and CGS. 

"E.K. and Elena's comprehensive expertise and creative mindset will help us 
support our deep focus on solving our customers' pain points. Both of their 
positions will be instrumental in driving and executing Suvoda's overall 
strategic initiatives and will play a key role as we continue our worldwide 
growth," said Jagath Wanninayake, President and CEO of the company. "I am 
particularly excited that both E.K. and Elena fit so well with our culture of 
making a meaningful contribution in accelerating the clinical trial process."

SOURCE:  Suvoda LLC

CONTACT: Amy Szwajkowski
         +1-610-572-2920 Ext. 3368
         aszwajkowski@suvoda.com